PMV Pharmaceuticals, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
PMVP on Nasdaq
Location
One Research Way, Princeton, NJ

Insiders trading volume in the past year

PMV Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Interwest Partners X Lp 10%+ Owner $10M Jul 13, 2021
Thilo Schroeder Director $2.46M Oct 6, 2021
David Henry Mack President and CEO, Director $1.11M Aug 13, 2024
Euclidean Capital LLC 10%+ Owner $283K Jun 11, 2021
Deepika Jalota Chief Development Officer $178K -$10.9K -5.75% Sep 11, 2024
Michael Carulli Chief Financial Officer $133K -$4.35K -3.17% Sep 11, 2024
Leila Alland Chief Medical Officer $102K Sep 15, 2023
Winston Kung Coo, Cfo May 12, 2023
Laurie Stelzer Director Jun 6, 2024
Richard A. Heyman Director Jun 6, 2024
Charles M. Baum Director Jun 6, 2024
Carol Giltner Gallagher Director Jun 6, 2024
Peter A. Thompson Director, 10%+ Owner Jun 2, 2021
Kirsten Flowers Director Jun 6, 2024
Arnold J. Levine Director Jun 6, 2024
Orbimed Advisors Llc 10%+ Owner Nov 22, 2023

Recent Insider Transactions by Companies or Individuals for PMV Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.